In the past decade there have been many advances for non-invasive aesthetic procedures. For fat loss the use of Ultheraapy and cool sculpting have developed. Longer lasting and fillers with higher viscosity solutions such as Voluma and Juvaderm plus and fillers that don’t attract as much water causing Tyndall Effect, the blue hue in areas under the eye. Allergan has developed Kybella which is similar to mesotherapy, deoxycholic acid, which is an acid that helps break down fat.
Kybella is the first drug to be FDA approved for the treatment of moderate-to- severe fat below the chin. A patient may receive approximately 45 injections in one treatment and can be repeated six times weekly. Kybella come in Patients undergoing treatment by Kybella may experience a painful sensation, and the tissues may appear bruised, swollen, feel numb, hard or appear red.
Kybella should be injected by a physician who is trained in this field and is licensed health care professional that can evaluate the patient for its use. A board-certified plastic surgeon can provide you with the both surgical and non-surgical options for the treatment of excessive skin in the chin.
Who is a poor candidate for Kybella?
Kybella should not be used for patients that have excessively loose skin or complete loss of the jawline as it does not remove redundant skin. Patient that have a retrusive or poorly developed chin may benefit from a genioplasty or chin augmentation with either a chin implant or surgical advancement of the chin.
Who is a good candidate for Kybella?
Kybella provides optimal results when skin has good elasticity, good snap-back and mild to moderate fat along the neck. Your doctor should be familiar with cephalometrics and assess the position of the chin in reference to the remainder of the face. Other options that may be necessary to attain a young and defined jaw line may be liposuctioning of the neck along with non-surgical skin tightening or a neck lift procedure with or without suture suspension to elevate loose tissue under the skin.